Showing 1 - 20 results of 27 for search 'Isabelle Treilleux', query time: 0.05s
Refine Results
-
1
-
2
Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca2+ traffic and response to neoadjuvant chemotherapy by Minh Quang Duong, Rudy Gadet, Isabelle Treilleux, Stéphane Borel, Adrien Nougarède, Olivier Marcillat, Philippe Gonzalo, Ivan Mikaelian, Nikolay Popgeorgiev, Ruth Rimokh, Germain Gillet
Published 2023-07-01
Article -
3
Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancer by Sonia Brahim, Ana-Maria Negulescu, Clara Geneste, Thomas Schott, Shuheng Lin, Louis-Oscar Morel, Nicolas Rama, Nicolas Gadot, Isabelle Treilleux, Patrick Mehlen, Olivier Meurette
Published 2023-02-01
Article -
4
Non-canonical NOTCH3 signalling limits tumour angiogenesis by Shuheng Lin, Ana Negulescu, Sirisha Bulusu, Benjamin Gibert, Jean-Guy Delcros, Benjamin Ducarouge, Nicolas Rama, Nicolas Gadot, Isabelle Treilleux, Pierre Saintigny, Olivier Meurette, Patrick Mehlen
Published 2017-07-01
Article -
5
ERα-36 regulates progesterone receptor activity in breast cancer by Henri-Philippe Konan, Loay Kassem, Soleilmane Omarjee, Ausra Surmieliova-Garnès, Julien Jacquemetton, Elodie Cascales, Amélie Rezza, Olivier Trédan, Isabelle Treilleux, Coralie Poulard, Muriel Le Romancer
Published 2020-05-01
Article -
6
ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice. by Anne Beghin, Stéphane Belin, Rouba Hage-Sleiman, Stéphanie Brunet Manquat, Sophie Goddard, Eric Tabone, Lars P Jordheim, Isabelle Treilleux, Marie-France Poupon, Jean-Jacques Diaz, Charles Dumontet
Published 2009-10-01
Article -
7
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer by Coralie Poulard, Thuy Ha Pham, Youenn Drouet, Julien Jacquemetton, Ausra Surmielova, Loay Kassem, Benoite Mery, Christine Lasset, Jonathan Reboulet, Isabelle Treilleux, Elisabetta Marangoni, Olivier Trédan, Muriel Le Romancer
Published 2023-08-01
Article -
8
BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges by Laetitia Collet, Laetitia Collet, Laetitia Collet, Brunhilde Hanvic, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin, Olivia Le Saux, Olivia Le Saux, Isabelle Ray-Coquard, Isabelle Ray-Coquard
Published 2024-03-01
Article -
9
Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis by Aude Chefdeville, Isabelle Treilleux, Marie-Eve Mayeur, Coline Couillault, Géraldine Picard, Chloé Bost, Karima Mokhtari, Alexandre Vasiljevic, David Meyronet, Véronique Rogemond, Dimitri Psimaras, Bertrand Dubois, Jérôme Honnorat, Virginie Desestret
Published 2019-03-01
Article -
10
Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1 by Elise Berthel, Anne Vincent, Lauriane Eberst, Adrian Gabriel Torres, Estelle Dacheux, Catherine Rey, Virginie Marcel, Hermes Paraqindes, Joël Lachuer, Frédéric Catez, Lluis Ribas de Pouplana, Isabelle Treilleux, Jean-Jacques Diaz, Nicole Dalla Venezia
Published 2020-04-01
Article -
11
Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History by Mehdi Brahmi, Tatiana Franceschi, Isabelle Treilleux, Daniel Pissaloux, Isabelle Ray-Coquard, Armelle Dufresne, Helene Vanacker, Melodie Carbonnaux, Pierre Meeus, Marie-Pierre Sunyach, Amine Bouhamama, Marie Karanian, Alexandra Meurgey, Jean-Yves Blay, Franck Tirode
Published 2020-09-01
Article -
12
Molecular Characterization of Ovarian Yolk Sac Tumor (OYST) by Khalil Hodroj, Aleksandra Stevovic, Valery Attignon, Domenico Ferraioli, Pierre Meeus, Sabrina Croce, Nicolas Chopin, Lea Rossi, Anne Floquet, Christine Rousset-Jablonski, Olivier Tredan, Frédéric Guyon, Isabelle Treilleux, Corinne Rannou, Marie Morfouace, Isabelle Ray-Coquard
Published 2021-01-01
Article -
13
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestran... by Julien Jacquemetton, Loay Kassem, Coralie Poulard, Ahmed Dahmani, Ludmilla De Plater, Elodie Montaudon, Laura Sourd, Ludivine Morisset, Rania El Botty, Sophie Chateau-Joubert, Sophie Vacher, Ivan Bièche, Isabelle Treilleux, Olivier Trédan, Elisabetta Marangoni, Muriel Le Romancer
Published 2021-05-01
Article -
14
MDR1-expressing CD4+ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response by Christophe Caux, Olivier Tredan, Thomas Duhen, Christine Ménétrier-Caux, Raphael Schneider, Laurie Besson, Isabelle Treilleux, Yenkel Grinberg-Bleyer, Anthony Di Roio, Margaux Hubert, Marion Bossennec, Céline Rodriguez, Guilhem Lalle, Lyvia Moudombi, Cyril Degletagne, Daniel J Campbell, Séverine Metzger
Published 2023-11-01
Article -
15
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. by Daniele Santini, Gaia Schiavon, Bruno Vincenzi, Laura Gaeta, Francesco Pantano, Antonio Russo, Cinzia Ortega, Camillo Porta, Sara Galluzzo, Grazia Armento, Nicla La Verde, Cinzia Caroti, Isabelle Treilleux, Alessandro Ruggiero, Giuseppe Perrone, Raffaele Addeo, Philippe Clezardin, Andrea Onetti Muda, Giuseppe Tonini
Published 2011-04-01
Article -
16
EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. by Anne-Pierre Morel, George W Hinkal, Clémence Thomas, Frédérique Fauvet, Stéphanie Courtois-Cox, Anne Wierinckx, Mojgan Devouassoux-Shisheboran, Isabelle Treilleux, Agnès Tissier, Baptiste Gras, Julie Pourchet, Isabelle Puisieux, Gareth J Browne, Douglas B Spicer, Joël Lachuer, Stéphane Ansieau, Alain Puisieux
Published 2012-01-01
Article -
17
CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes by Rodrigo Nalio Ramos, Céline Rodriguez, Margaux Hubert, Maude Ardin, Isabelle Treilleux, Carola H Ries, Emilie Lavergne, Sylvie Chabaud, Amélie Colombe, Olivier Trédan, Henrique Gomes Guedes, Fábio Laginha, Wilfrid Richer, Eliane Piaggio, José Alexandre M Barbuto, Christophe Caux, Christine Ménétrier‐Caux, Nathalie Bendriss‐Vermare
Published 2020-01-01
Article -
18
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3 by Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, Maxime Raddaz, Ellen Blanc, Olivier Msika, Isabelle Treilleux, Sophie Bachy, Anne Cattey-Javouhey, Pierre Guibert, Matthieu Sarabi, Pauline Rochefort, Pamela Funk-Debleds, Clélia Coutzac, Isabelle Ray-Coquard, Patrice Peyrat, Pierre Meeus, Michel Rivoire, Aurélien Dupré, Ana Hennino
Published 2022-04-01
Article -
19
Correction: Inactivation of TIF1γ Cooperates with Kras to Induce Cystic Tumors of the Pancreas. by David F. Vincent, Kai-Ping Yan, Isabelle Treilleux, Fabien Gay, Vanessa Arfi, Bastien Kaniewski, Julien C. Marie, Florian Lepinasse, Sylvie Martel, Sophie Goddard-Leon, Juan L. Iovanna, Pierre Dubus, Stéphane Garcia, Alain Puisieux, Ruth Rimokh, Nabeel Bardeesy, Jean-Yves Scoazec, Régine Losson, Laurent Bartholin
Published 2009-08-01
Article -
20
Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VI... by Nour‐El‐Houda Mourksi, Cécile Dalban, Amélie Colombe‐Vermorel, Laetitia Odeyer, Valentin Simioni, Jean‐Sébastien Frenel, Michel Fabbro, Fernando Bazan, Sophie Abadie‐Lacourtoisie, Elodie Coquan, Séverine Martinez, Gwenaelle Garin, Séverine Tabone‐Eglinger, Isabelle Treilleux, Sylvie Chabaud, David Pérol, Isabelle Ray‐Coquard, Pierre‐Etienne Heudel, Jean‐Jacques Diaz, Virginie Marcel
Published 2023-01-01
Article